Brief: CytoTools's Subsidiary CytoPharma Applies For Patent In Field Of Oncology
June 14 (Reuters) - CYTOTOOLS AG T5OG.DE :
* CYTOPHARMA, SUBSIDIARY OF CYTOTOOLS, PROTECTS NEW DRUG
CANDIDATES BY APPLYING FOR A PATENT FOR USE IN ONCOLOGY
* NEW DRUG CANDIDATES OPEN UP THE POSSIBILITY OF INNOVATIVE
CANCER
THERAPY
Source text for Eikon: ID:nEQ8R4J0Va
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)